New bid for Allergan not even close, board tells suitor Valeant

Posted: June 11, 2014 at 2:45 a.m.

Allergan's board has unanimously rejected the latest takeover bid from Valeant Pharmaceuticals, and the Botox maker said the offer isn't even worth talking about.

This story is only available from our archives.